drugset / Trial / NCT06142656
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
RandomizedParallel-groupSingle-blindTreatment
Summary
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM
Timeline
- Start
- 2023-11-25
- Primary completion
- 2025-12-01
- Completion
- 2026-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 850 mg | Oral |
| Comparator | Vildagliptin | Other / unclassified | 50 mg | Oral |